Sugarman Rogers has earned a reputation as one of Boston’s leading firms in the handling of individual and mass-tort or class-action claims against the pharmaceutical and medical-device industries. We leverage our experience with these complex cases to provide extraordinarily effective representation to our clients. In addition, our attorneys are supported by sophisticated in-house personal-injury paralegals with over 20 years of experience reviewing medical records and performing investigations.

We have taken leadership positions in a number of significant national lawsuits against pharmaceutical and medical device companies, and we have established relationships with other mass-tort lawyers throughout the country, as well as with nationally recognized experts who can testify effectively about the dangers that defective drugs and medical devices pose to consumers. The chair of this group, Michael Appel, has played leading roles in significant mass-tort cases against pharmaceutical and medical device companies such as:

• Plaintiffs’ co-lead counsel in In re: Consolidated Fresenius Cases, an action against the manufacturer of GranuFlo, a defective product used during kidney dialysis, which resulted in a $250 million global settlement.
• Plaintiffs’ executive-committee member in In re: Specially Assigned Transvaginal Mesh Implant Cases.
• Plaintiffs’ lead coordinating counsel in In re: Massachusetts State Court Diet Drug Litigation, in which he helped obtain settlements for over 2,300 individuals injured by the diet drugs Fen-Phen and Redux.
• Plaintiffs’ co-liaison counsel in In re: Specially Assigned Taxus Stent Cases.
• Plaintiffs’ co-lead counsel in Downie vs. Atrium, involving claims of defect in C-QUR hernia mesh.

Sugarman Rogers has also obtained substantial recoveries for individuals in defective pharmaceutical cases, including a settlement of $2.9 million on behalf of the estate of a woman who died after suffering acute liver failure following brief use of a popular anti-depressant drug.

We are currently accepting cases involving the following drugs and medical devices:

1. Hernia meshes, especially C-QUR mesh and Physiomesh – research has linked these products to hernia recurrence and other complications.
2. Proton-pump inhibitors such as Nexium, Prevacid and Prilosec – these drugs have been linked to severe kidney problems.
3. Fluoroquinolones such as Levaquin – research has shown these drugs can cause nerve and tendon damage.
4. Essure birth-control devices – these devices are linked to severe pain and unintended pregnancy.
5. Dupuy Pinnacle hip prostheses – these devices are linked to pseudotumors and cobalt and chromium metallosis.

Contact us to request a case evaluation or for more information.